Investors / Netherlands / NextGen Ventures
NextGen Ventures
Venture capital · Ede, Netherlands · Europe
NextGen Ventures is a venture capital firm that invests in early-stage digital health and medtech startups. It provides seed capital and beyond, and supports its portfolio companies with an active role and network.
Invests inHealthcare & Biotech
In its own wordsdigital healthmedtechhealthcaremedical technologyseedearly stage
Your fit with NextGen Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNextGen Ventures lists 17 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Seed, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (89%) and AI & Machine Learning (11%). 92% of its companies are based in Netherlands. It invests most often alongside Brabant Development Agency (BOM), Invest-NL and Y Combinator.
Counts come from funding rounds that name NextGen Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not NextGen Ventures' whole history. Rounds on record name 3 companies; its own site lists 17. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 67% |
| Series A | 0% |
| Series B | 33% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 44th | 17 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 80th | 67% of entries at pre-seed or seed |
| Evidence | 81th | 12% of companies confirmed by a round |
| Sector focus | 95th | 89% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Brabant Development Agency (BOM) | 3 |
| Invest-NL | 3 |
| Y Combinator | 2 |
| Act One Ventures | 1 |
| Advisors.Fund | 1 |
| Antler | 1 |
| Borski Fund | 1 |
| Brightlands Venture Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1694%
- No longer answers00%
- Points to another company16%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 89% | 15% |
| AI & Machine Learning | 11% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Brabant Development Agency (BOM)
Compare NextGen Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with NextGen Ventures| Date | Company | Stage |
|---|---|---|
| 7 Feb 2026 | Seed | |
| 7 Jan 2026 | Seed | |
| 4 Feb 2025 | Series B |
Round details for NextGen Ventures
Amounts, full round histories and every co-investor in NextGen Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
17 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AMT Medical develops and markets a system for coronary bypass surgery. | Healthcare & Biotech | Portfolio page | ||
| Attendi provides a speech-driven reporting system for healthcare professionals to reduce time spent on software and increase attention to clients. | Healthcare & Biotech | Portfolio page | ||
| Bloomlife provides remote monitoring services for high-risk pregnancies | Healthcare & Biotech | Portfolio page | ||
| Elanza provides software for planning and managing flexible healthcare workers | Healthcare & Biotech | Portfolio page | ||
| Flux Robotics develops a robotic navigation platform for complex vascular blockages using magnetic vascular navigation for endovascular robotics | Healthcare & Biotech | Portfolio page | ||
AI & Machine LearningAI & Machine Learning | Feb 2026Seed | Funding round | ||
| Implican develops a new approach to colorectal anastomosis designed around precise tissue contact and primary wound healing. | Healthcare & Biotech | Portfolio page | ||
| Manometric creates custom 3D-printed hand and foot orthoses | Healthcare & Biotech | Portfolio page | ||
| Momo Medical provides an app for caregivers to monitor residents in memory care communities | Healthcare & Biotech | Portfolio page | ||
| Moveshelf provides an infrastructure for movement analysis | Healthcare & Biotech | Portfolio page | ||
| Plasmacure is a medical technology company developing a new therapeutic platform modality with traction across infection control, tissue regeneration and wounds. | Healthcare & Biotech | Portfolio page | ||
| ShanX Medtech is developing novel diagnostics for antimicrobial susceptibility testing | Healthcare & Biotech | Jan 2026Seed | Page + round | |
| Sirius Medical Systems develops and provides a real-time navigation system for breast surgeons | Healthcare & Biotech | Feb 2025Series B | Page + round | |
| STENTiT develops a temporary vascular support structure for endovascular treatments | Healthcare & Biotech | Portfolio page | ||
| Syntilio provides a platform for personalized and efficient remote care | Healthcare & Biotech | Portfolio page | ||
| TRACER provides clinical research and imaging services for radiopharmaceuticals and drug development | Healthcare & Biotech | Portfolio page | ||
| Vivalyx develops a preservation solution for donor organs to improve their quality and viability for transplantation | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- nextgenventures.nl
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 4 Feb 2025
- Companies checked
- 17
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get NextGen Ventures' profile as data
Pull NextGen Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/nextgenventures.nl
# also
GET /v1/firms/nextgenventures.nl/portfolio
GET /v1/firms/nextgenventures.nl/coinvestors
GET /v1/firms/nextgenventures.nl/news